Aromatase Inhibitor–Mediated Downregulation of INrf2 (Keap1) Leads to Increased Nrf2 and Resistance in Breast Cancer
Molecular Cancer Therapeutics (2015) - Comments
pubmed: 25976679  doi: 10.1158/1535-7163.mct-14-0672  issn: 1538-8514  issn: 1535-7163 

Raju Khatri, Preeti Shah, Rupa Guha, Feyruz V. Rassool, Alan E. Tomkinson, Angela Brodie, Anil K. Jaiswal